444 related articles for article (PubMed ID: 28334779)
61. An evolved AAV variant enables efficient genetic engineering of murine T cells.
Nyberg WA; Ark J; To A; Clouden S; Reeder G; Muldoon JJ; Chung JY; Xie WH; Allain V; Steinhart Z; Chang C; Talbot A; Kim S; Rosales A; Havlik LP; Pimentel H; Asokan A; Eyquem J
Cell; 2023 Jan; 186(2):446-460.e19. PubMed ID: 36638795
[TBL] [Abstract][Full Text] [Related]
62. CRISPR-Cas9 knockin mice for genome editing and cancer modeling.
Platt RJ; Chen S; Zhou Y; Yim MJ; Swiech L; Kempton HR; Dahlman JE; Parnas O; Eisenhaure TM; Jovanovic M; Graham DB; Jhunjhunwala S; Heidenreich M; Xavier RJ; Langer R; Anderson DG; Hacohen N; Regev A; Feng G; Sharp PA; Zhang F
Cell; 2014 Oct; 159(2):440-55. PubMed ID: 25263330
[TBL] [Abstract][Full Text] [Related]
63. Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells.
Wang Y; Wang Y; Chang T; Huang H; Yee JK
Nucleic Acids Res; 2017 Mar; 45(5):e29. PubMed ID: 27899664
[TBL] [Abstract][Full Text] [Related]
64. Amphipathic Cell-Penetrating Peptide-Aided Delivery of Cas9 RNP for In Vitro Gene Editing and Correction.
Öktem M; Mastrobattista E; de Jong OG
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896260
[TBL] [Abstract][Full Text] [Related]
65. Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 RNP.
Chen K; Han H; Zhao S; Xu B; Yin B; Trinidad M; Burgstone BW; Murthy N; Doudna JA
bioRxiv; 2023 Nov; ():. PubMed ID: 38014175
[TBL] [Abstract][Full Text] [Related]
66. One-step generation of modular CAR-T cells with AAV-Cpf1.
Dai X; Park JJ; Du Y; Kim HR; Wang G; Errami Y; Chen S
Nat Methods; 2019 Mar; 16(3):247-254. PubMed ID: 30804551
[TBL] [Abstract][Full Text] [Related]
67. Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing.
Smith LJ; Wright J; Clark G; Ul-Hasan T; Jin X; Fong A; Chandra M; St Martin T; Rubin H; Knowlton D; Ellsworth JL; Fong Y; Wong KK; Chatterjee S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7379-E7388. PubMed ID: 30018062
[TBL] [Abstract][Full Text] [Related]
68. Increasing the Specificity of AAV-Based Gene Editing through Self-Targeting and Short-Promoter Strategies.
Breton C; Furmanak T; Avitto AN; Smith MK; Latshaw C; Yan H; Greig JA; Wilson JM
Mol Ther; 2021 Mar; 29(3):1047-1056. PubMed ID: 33359790
[TBL] [Abstract][Full Text] [Related]
69. Delivering Base Editors In Vivo by Adeno-Associated Virus Vectors.
Lim CKW; Miskalis AJ; Perez-Pinera P; Gaj T
Methods Mol Biol; 2023; 2606():135-158. PubMed ID: 36592313
[TBL] [Abstract][Full Text] [Related]
70. TESOGENASE, An Engineered Nuclease Editor for Enhanced Targeted Genome Integration.
Nam H; Xie K; Majumdar I; Yang S; Starzyk J; Lee D; Shan R; Li J; Wu H
bioRxiv; 2023 Aug; ():. PubMed ID: 37693500
[TBL] [Abstract][Full Text] [Related]
71. AAV-mediated gene editing via double-strand break repair.
Hirsch ML; Samulski RJ
Methods Mol Biol; 2014; 1114():291-307. PubMed ID: 24557911
[TBL] [Abstract][Full Text] [Related]
72. Lipofection of Non-integrative CRISPR/Cas9 Ribonucleoproteins in Male Germline Stem Cells: A Simple and Effective Knockout Tool for Germline Genome Engineering.
Obermeier M; Vadolas J; Verhulst S; Goossens E; Baert Y
Front Cell Dev Biol; 2022; 10():891173. PubMed ID: 35774227
[TBL] [Abstract][Full Text] [Related]
73. Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction.
Suzuki K; Yamamoto M; Hernandez-Benitez R; Li Z; Wei C; Soligalla RD; Aizawa E; Hatanaka F; Kurita M; Reddy P; Ocampo A; Hishida T; Sakurai M; Nemeth AN; Nuñez Delicado E; Campistol JM; Magistretti P; Guillen P; Rodriguez Esteban C; Gong J; Yuan Y; Gu Y; Liu GH; López-Otín C; Wu J; Zhang K; Izpisua Belmonte JC
Cell Res; 2019 Oct; 29(10):804-819. PubMed ID: 31444470
[TBL] [Abstract][Full Text] [Related]
74. CRISPR/Cas9 + AAV-mediated Intra-embryonic Gene Knocking in Mice.
Mizuno N; Mizutani E; Sato H; Kasai M; Nakauchi H; Yamaguchi T
Bio Protoc; 2019 Jul; 9(13):e3295. PubMed ID: 33654808
[TBL] [Abstract][Full Text] [Related]
75. A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons.
Tervo DG; Hwang BY; Viswanathan S; Gaj T; Lavzin M; Ritola KD; Lindo S; Michael S; Kuleshova E; Ojala D; Huang CC; Gerfen CR; Schiller J; Dudman JT; Hantman AW; Looger LL; Schaffer DV; Karpova AY
Neuron; 2016 Oct; 92(2):372-382. PubMed ID: 27720486
[TBL] [Abstract][Full Text] [Related]
76. CRISPR-Cas9-directed gene tagging using a single integrase-defective lentiviral vector carrying a transposase-based Cas9 off switch.
Thomsen EA; Skipper KA; Andersen S; Haslund D; Skov TW; Mikkelsen JG
Mol Ther Nucleic Acids; 2022 Sep; 29():563-576. PubMed ID: 36090759
[TBL] [Abstract][Full Text] [Related]
77. Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification.
Haldrup J; Andersen S; Labial ARL; Wolff JH; Frandsen FP; Skov TW; Rovsing AB; Nielsen I; Jakobsen TS; Askou AL; Thomsen MK; Corydon TJ; Thomsen EA; Mikkelsen JG
Nucleic Acids Res; 2023 Oct; 51(18):10059-10074. PubMed ID: 37678882
[TBL] [Abstract][Full Text] [Related]
78. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA
Lee K; Conboy M; Park HM; Jiang F; Kim HJ; Dewitt MA; Mackley VA; Chang K; Rao A; Skinner C; Shobha T; Mehdipour M; Liu H; Huang WC; Lan F; Bray NL; Li S; Corn JE; Kataoka K; Doudna JA; Conboy I; Murthy N
Nat Biomed Eng; 2017; 1():889-901. PubMed ID: 29805845
[TBL] [Abstract][Full Text] [Related]
79. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.
Banskota S; Raguram A; Suh S; Du SW; Davis JR; Choi EH; Wang X; Nielsen SC; Newby GA; Randolph PB; Osborn MJ; Musunuru K; Palczewski K; Liu DR
Cell; 2022 Jan; 185(2):250-265.e16. PubMed ID: 35021064
[TBL] [Abstract][Full Text] [Related]
80. Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases.
Esposito F; Dell'Aquila F; Rhiel M; Auricchio S; Chmielewski KO; Andrieux G; Ferla R; Horrach PS; Padmanabhan A; Di Cunto R; Notaro S; Santeularia ML; Boerries M; Dell'Anno M; Nusco E; Padula A; Nutarelli S; Cornu TI; Sorrentino NC; Piccolo P; Trapani I; Cathomen T; Auricchio A
Cell Rep Med; 2024 Jun; ():101619. PubMed ID: 38897206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
